XPH : SPDR S&P Pharmaceuticals ETF

XPH is a Sector Equity Market Healthcare with LOW fees.

XPH

SPDR S&P Pharmaceuticals ETF

FI Score

59 /100

Diversification Rating

10 /10

Expense Ratio Rating

9 /10

Expense Rating

7 /10

Market Score

3 /10

Category Score

0 /10

Market Size

3 /10

Similar Funds

We found 107 Sector Equity Healthcare funds. Here they are ordered by FI Score.

Compare XPH vs SHISX

43% FI Score
  • shisx
  • Mutual Fund
  • Sector Equity
  • Healthcare

BlackRock Health Sciences Opportunities Portfolio Service Shares

Expenses: 1.15% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs GNOM

43% FI Score
  • gnom
  • ETF
  • Sector Equity
  • Healthcare

Global X Genomics & Biotechnology ETF

Expenses: 0.68% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs SHSAX

43% FI Score
  • shsax
  • Mutual Fund
  • Sector Equity
  • Healthcare

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

Expenses: 1.12% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs FSHCX

42% FI Score
  • fshcx
  • Mutual Fund
  • Sector Equity
  • Healthcare

Fidelity® Select Health Care Services Portfolio

Expenses: 0.75% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs FTXH

42% FI Score
  • ftxh
  • ETF
  • Sector Equity
  • Healthcare

First Trust Nasdaq Pharmaceuticals ETF

Expenses: 0.60% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs BBC

39% FI Score
  • bbc
  • ETF
  • Sector Equity
  • Healthcare

Virtus LifeSci Biotech Clinical Trials ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs CNCR

39% FI Score
  • cncr
  • ETF
  • Sector Equity
  • Healthcare

Loncar Cancer Immunotherapy ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs BBP

38% FI Score
  • bbp
  • ETF
  • Sector Equity
  • Healthcare

Virtus LifeSci Biotech Products ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs FPHAX

38% FI Score
  • fphax
  • Mutual Fund
  • Sector Equity
  • Healthcare

Fidelity® Select Pharmaceuticals Portfolio

Expenses: 0.77% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare XPH vs PHLAX

37% FI Score
  • phlax
  • Mutual Fund
  • Sector Equity
  • Healthcare

PGIM Jennison Health Sciences Fund- Class A

Expenses: 1.15% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo